Cance W G, Liu E T
Department of Surgery, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine 27599, USA.
Breast Cancer Res Treat. 1995 Jul;35(1):105-14. doi: 10.1007/BF00694751.
The family of protein kinases includes many oncogenes and growth factor receptors, many of which have been linked to the pathogenesis and progression of cancer. Protein tyrosine kinases such as HER-2/c-erbB-2 and the epidermal growth factor receptor (EGFR) have been linked specifically to breast cancer, and perturbations of HER-2 affect response to chemotherapy. We have reviewed the biology of protein kinases in human breast cancer, as well as their translational applications to breast cancer patients. We have studied the spectrum of protein kinases expressed in human breast cancer cells and have identified four protein kinases with potentially important functions in breast cancer: rak (src-related), TK5 (which we now designate JAK3), the focal adhesion kinase (FAK), and STK1 (human M015/CAK). We describe the potential significance of these genes in breast cancer, as well as our methodology for identifying and characterizing novel genes in breast cancer.
蛋白激酶家族包括许多癌基因和生长因子受体,其中许多已与癌症的发病机制和进展相关联。诸如HER-2/c-erbB-2和表皮生长因子受体(EGFR)等蛋白酪氨酸激酶已被明确与乳腺癌相关,并且HER-2的扰动会影响对化疗的反应。我们综述了人类乳腺癌中蛋白激酶的生物学特性,以及它们在乳腺癌患者中的转化应用。我们研究了人类乳腺癌细胞中表达的蛋白激酶谱,并鉴定出在乳腺癌中具有潜在重要功能的四种蛋白激酶:rak(与src相关)、TK5(我们现在将其命名为JAK3)、粘着斑激酶(FAK)和STK1(人类M015/CAK)。我们描述了这些基因在乳腺癌中的潜在意义,以及我们在乳腺癌中鉴定和表征新基因的方法。